Products
Cutting edge products for testing samples from viral hemorrhagic fevers and other neglected tropical diseases. Now includes SARS-CoV-2 tests.
The Science
At Zalgen, Science is applied through combining cutting-edge technology, gifted researchers and energetic collaborators to discover, develop and apply innovative, practical and affordable products to address neglected tropical diseases.
About Zalgen Labs
At Zalgen Labs, we are dedicated to making a meaningful difference in developing and deploying medical countermeasures against pandemic viruses including SARS-CoV-2 and neglected tropical diseases.
News & Events
Read the latest information on how Zalgen and our collaboration partners are making a difference.
Recent paper in Science reaffirms necessity for increased awareness of Lassa virus infections
May 2024 READ THE ARTICLE The article Roberts, L. (Feb 2024). A Spiking Fever… Science, 383 (6685)….
Zalgen Immunotherapeutic Confers Complete Protection Against Advanced Multilineage Lassa Infections in Nonhuman Primates
Article in Proceedings of the National Academy of Sciences (PNAS) reports data from the latest study at the University of Texas Medical Branch…
Zalgen Relocates Headquarters to Life Sciences Epicenter in Frederick, Maryland
Frederick, MD, December 16, 2021 – One of the leading biotechnology and diagnostics companies in the field…
Zalgen Awarded CEPI Contract to Provide Test Kits for Largest Ever Lassa Fever Study in West Africa
Three-year contract leading to advance clinical trials for Lassa Fever vaccines reaffirms Zalgen’s focus on preparedness and…
Zalgen Licenses Lassa Virus Diagnostic Technology from The Scripps Research Institute
Scripps proprietary glycoprotein technology key to development of new diagnostic tests enabling the design of better, more…
Zalgen Immunotherapeutic Demonstrates 100% Effectiveness Against Advanced Lassa Infections in Non-Human Primates
Article in Nature Medicine reports data from study at the University of Texas Medical Branch at Galveston…
Zalgen Antibodies Used in Solving First Lassa Virus Glycoprotein Trimer Structure
Article in Science provides template for advanced vaccine and immunotherapeutic design against Lassa Fever, a major threat…
Zalgen and NOWDiagnostics Announce Strategic Collaboration to Advance Novel Rapid Diagnostic Tests for Tropical Diseases
Collaboration combines Zalgen’s leadership in hemorrhagic fevers and other tropical diseases with NOWDiagnostics’ unique ADEXUSDx® rapid test…
Zalgen Labs Introduces Viral Diagnostics Business, Opens Advanced Product Development Center in Colorado
Zalgen Labs, a biotechnology and diagnostics company focused on high-impact, neglected infectious diseases, announced that it has…
Looking to Start a Career or just have questions about our products?
Join our growing teams in Frederick MD and Aurora CO.
Zalgen Labs has been featured in the following journals and publications:
